AU4698499A - Cationic amphiphile micellar complexes - Google Patents
Cationic amphiphile micellar complexes Download PDFInfo
- Publication number
- AU4698499A AU4698499A AU46984/99A AU4698499A AU4698499A AU 4698499 A AU4698499 A AU 4698499A AU 46984/99 A AU46984/99 A AU 46984/99A AU 4698499 A AU4698499 A AU 4698499A AU 4698499 A AU4698499 A AU 4698499A
- Authority
- AU
- Australia
- Prior art keywords
- micellar
- lipid
- complex
- complexes
- biologically active
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6907—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a microemulsion, nanoemulsion or micelle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6911—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nanotechnology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8987998P | 1998-06-19 | 1998-06-19 | |
US60089879 | 1998-06-19 | ||
PCT/US1999/013875 WO1999065461A2 (en) | 1998-06-19 | 1999-06-18 | Cationic amphiphile micellar complexes |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4698499A true AU4698499A (en) | 2000-01-05 |
Family
ID=22220044
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU46984/99A Abandoned AU4698499A (en) | 1998-06-19 | 1999-06-18 | Cationic amphiphile micellar complexes |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1085857A2 (ja) |
JP (1) | JP2002518313A (ja) |
AU (1) | AU4698499A (ja) |
CA (1) | CA2335638A1 (ja) |
WO (1) | WO1999065461A2 (ja) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2370690A1 (en) * | 1999-04-20 | 2000-10-26 | The University Of British Columbia | Cationic peg-lipids and methods of use |
US6852334B1 (en) | 1999-04-20 | 2005-02-08 | The University Of British Columbia | Cationic peg-lipids and methods of use |
US7189705B2 (en) | 2000-04-20 | 2007-03-13 | The University Of British Columbia | Methods of enhancing SPLP-mediated transfection using endosomal membrane destabilizers |
AU5454801A (en) * | 2000-04-20 | 2001-11-07 | Univ British Columbia | Methods of enhancing splp-mediated transfection using endosomal membrane destabilizers |
JP4590519B2 (ja) * | 2006-09-22 | 2010-12-01 | 独立行政法人産業技術総合研究所 | 腸管吸収制御性リポソーム |
BRPI0822924A2 (pt) * | 2008-06-19 | 2015-06-23 | Nippon Shinyaku Co Ltd | Veículo de fármaco |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5286634A (en) * | 1989-09-28 | 1994-02-15 | Stadler Joan K | Synergistic method for host cell transformation |
US5843473A (en) * | 1989-10-20 | 1998-12-01 | Sequus Pharmaceuticals, Inc. | Method of treatment of infected tissues |
WO1996014864A1 (en) * | 1994-11-09 | 1996-05-23 | The Regents Of The University Of California | Immunoliposomes that optimize internalization into target cells |
DE69634084T2 (de) * | 1995-06-07 | 2005-12-08 | Inex Pharmaceuticals Corp. | Herstellung von lipid-nukleinsäure partikeln duch ein hydrophobische lipid-nukleinsäuree komplexe zwischenprodukt und zur verwendung in der gentransfer |
-
1999
- 1999-06-18 EP EP99930442A patent/EP1085857A2/en not_active Withdrawn
- 1999-06-18 CA CA002335638A patent/CA2335638A1/en not_active Abandoned
- 1999-06-18 AU AU46984/99A patent/AU4698499A/en not_active Abandoned
- 1999-06-18 JP JP2000554341A patent/JP2002518313A/ja active Pending
- 1999-06-18 WO PCT/US1999/013875 patent/WO1999065461A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1085857A2 (en) | 2001-03-28 |
WO1999065461A3 (en) | 2000-02-24 |
WO1999065461A9 (en) | 2001-02-01 |
JP2002518313A (ja) | 2002-06-25 |
CA2335638A1 (en) | 1999-12-23 |
WO1999065461A2 (en) | 1999-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20010048940A1 (en) | Cationic amphiphile micellar complexes | |
US5990089A (en) | Self-assembling polynucleotide delivery system comprising dendrimer polycations | |
Mahato et al. | Cationic lipid-based gene delivery systems: pharmaceutical perspectives | |
EP0814777B1 (en) | Stable lipid-comprising drug delivery complexes and methods for their production | |
CA2163364C (en) | Self-assembling polynucleotide delivery system comprising dendrimer polycations | |
US6008202A (en) | Stable lipid-comprising drug delivery complexes and methods for their production | |
US5851818A (en) | Condensed plasmid-liposome complex for transfection | |
WO1998051285A2 (en) | Cationic amphiphile formulations | |
JP2000516209A (ja) | カチオン性両親媒性物質/dna複合体 | |
CA2115364A1 (en) | Composition and method for treating cystic fibrosis | |
US6133026A (en) | Condensed plasmid-liposome complex for transfection | |
AU4698499A (en) | Cationic amphiphile micellar complexes | |
US6465007B1 (en) | Transgene expression in polarized cells | |
HUI et al. | FRONTIERS IN HUMAN GENETICS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |